The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Chimeric Nucleases Stimulate Gene Targeting in Human Cells
Abstract
Correction of gene defects in human somatic cells by targeting as has been used in murine embryonic stem cells (1, 2) has been precluded by the low spontaneous rate of gene targeting (3). However, creation of a DNA double-stranded break (DSB) in the genomic target (DSB-GT) can stimulate homologous recombination by over 1000-fold (4). \n \nWe can rapidly and quantitatively measure gene targeting by correcting a mutation in a green fluorescent protein (GFP) gene that has been stably integrated into the genome (5) (fig. S1). With an optimized GFP gene targeting system, the introduction of a DSB by I–Sce I (Sce) stimulated GT >40,000-fold and the absolute rate of gene targeting reached 3 to 5% (fig. S2). Such a system, however, depends on the prior introduction of a Sce binding site into the target gene and cannot be used for endogenous genes. Chimeric nucleases (CNs) have the potential to create sequence-specific DSBs (6). CNs—fusions between zinc finger binding DNA binding domains and the endonuclease domain of Fok I—can sitespecifically cleave naked DNA in vitro (6), extrachromosomal DNA in Xenopus oocytes (7), and chromosomal DNA in Drosophila (8). CNs work as dimers, and their efficiency depends on the spacing and orientation of the zinc finger binding sites with respect to the length of the amino acid linker between the DNA binding and endonuclease domains (7, 9). \n \nQQR is an artificial zinc finger DNA binding domain that recognizes the sequence 5′-GGGGAAGAA-3′ with nanomolar affinity (10). We modified QQR chimeric nucleases (QQR-CNs) (7, 9) (Fig. 1A) and tested whether they stimulated gene targeting (Fig. 1B). The background rate of gene targeting was 0.71 events per million transfected cells (fig. S1C). QQRL18-CN stimulated gene targeting 17-fold on target QQR6 and 260-fold on target QQR8 (Fig. 1B). QQRL0-CN did not stimulate gene targeting on target QQR8, but it was as efficient as Sce in stimulating gene targeting by over 2000-fold on target QQR6 (Fig. 1B). QQRL18-CN showed some preference for an 8–base pair (bp) spacing between binding sites whereas QQRL0-CN preferred 6-bp spacing. Thus, removing the linker between the zinc spacfinger and the nuclease domains increased the activity and specificity of the fusion protein in mammalian cells. As controls, we showed that the CNs did not stimulate gene targeting if (i) they lacked a nuclear localization signal, (ii) there was a single binding site rather than an inverted repeat binding site in the target, and (iii) the cognate binding site was changed. Thus, homodimers of CNs are potent stimulators of gene targeting in human somatic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, if the nuclease action mutates unintended targets that are important for cellular physiology, the treated cells may become dysfunctional or even die [61,62,63].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [62]
In the citing paper
“The fundamental safety concern for using ZFN mediated gene disruption for human therapy is the specificity of gene targeting.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [62]
Citations
Cites
Altering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 2,037
DNA Recognition by Cys2His2 Zinc Finger Proteins
Wolfe, S. A., Nekludova, L., & Pabo, C. O. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.183 · Cited by 1,053
Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases
Bibikova, M., Golic, M., Golic, K. G., & Carroll, D. (2002) · Genetics · doi:10.1093/genetics/161.3.1169 · Cited by 860
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells
Doetschman, T., Gregg, R., Maeda, N., Hooper, M., Melton, D., Thompson, S., & Smithies, O. (1987) · Nature · doi:10.1038/330576a0 · Cited by 756
Stimulation of Homologous Recombination through Targeted Cleavage by Chimeric Nucleases
Bibikova, M. V., Carroll, D., Segal, D. J., Trautman, J. K., Smith, J., Kim, Y., & Chandrasegaran, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.289-297.2001 · Cited by 614
Smith, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.17.3361 · Cited by 425
Genetic manipulation of genomes with rare-cutting endonucleases
Jasin, M. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)10019-6 · Cited by 391
Positive genetic selection for gene disruption in mammalian cells by homologous recombination.
Sedivy, J. M., & Sharp, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.227 · Cited by 119
Specific DNA-RNA Hybrid Binding by Zinc Finger Proteins
Shi, Y., & Berg, J. M. (1995) · Science · doi:10.1126/science.7536342 · Cited by 86
Chimeric Restriction Enzymes: What Is Next?
Chandrasegaran, S., & Smith, J. (1999) · Biological Chemistry · doi:10.1515/bc.1999.103 · Cited by 85
Research works printed but not linked: 1
- S. Chandrasegaran, J. Smith, Biol. Chem.380, 841 (1999).
Cited by
Sorted by citations
Items 401–500 of 740
High, K. A. (2005) · Nature · doi:10.1038/435577a · Cited by 19
Mobile group II intron targeting: applications in prokaryotes and perspectives in eukaryotes
Cui, X. (2007) · Frontiers in bioscience · doi:10.2741/2442 · Cited by 19
CRISPR/cas-mediated genome editing in sorghum — recent progress, challenges and prospects
Parikh, A., Brant, E. J., Baloglu, M. C., & Altpeter, F. (2021) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-021-10215-y · Cited by 18
Applications of multiplexed CRISPR–Cas for genome engineering
Cheng, H., Jeong, E., & Cho, S. W. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01500-6 · Cited by 22
Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo
Elbadawy, H. M., Gailledrat, M., Desseaux, C., Salvalaio, G., Iorio, E. D., Ferrari, B., Bertolin, M., Barbaro, V., Parekh, M., Gayon, R., et al. (2014) · Gene Therapy · doi:10.1038/gt.2013.82 · Cited by 18
Genome engineering of isogenic human ES cells to model autism disorders
Martinez, R. A., Stein, J. L., Krostag, A.-R., Nelson, A. M., Marken, J., Menon, V., May, R., Yao, Z., Kaykas, A., Geschwind, D. H., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv164 · Cited by 20
Tian, K. V., Guo, Y., Zou, B., Wang, L., Zhang, Y., Qi, Z., Zhou, J., Wang, X., Zhou, G., Wei, L., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa843 · Cited by 18
Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools
Nafissi, N., & Földvári, M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00355 · Cited by 18
Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome Modification
Wilson, K. A., McEwen, A. E., Pruett‐Miller, S. M., Zhang, J., Kildebeck, E., & Porteus, M. H. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.13 · Cited by 18
Self-citationKatada, H., Harumoto, T., Shigi, N., & Komiyama, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks185 · Cited by 18
Custom-Designed Molecular Scissors for Site-Specific Manipulation of the Plant and Mammalian Genomes
Kandavelou, K., & Chandrasegaran, S. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-483-4_40 · Cited by 18
Manotham, K., Chattong, S., & Setpakdee, A. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0130-6 · Cited by 20
Generation of targeted mouse mutants by embryo microinjection of TALENs
Wefers, B., Ortiz, O., Wurst, W., & Kühn, R. (2014) · Methods · doi:10.1016/j.ymeth.2014.01.002 · Cited by 18
Low-Dose Irradiation Enhances Gene Targeting in Human Pluripotent Stem Cells
Hatada, S., Subramanian, A., Mandefro, B., Ren, S., Kim, H. W., Tang, J., Funari, V. A., Baloh, R. H., Sareen, D., Arumugaswami, V., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0050 · Cited by 17
Synthetic strategies for plant signalling studies: molecular toolbox and orthogonal platforms
Braguy, J., & Zurbriggen, M. D. (2016) · The Plant Journal · doi:10.1111/tpj.13218 · Cited by 19
Synthetic zinc finger peptides: old and novel applications
Corbi, N., Libri, V., Onori, A., & Passananti, C. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-047 · Cited by 18
The discovery of zinc fingers and their development for practical applications in gene regulation
Klug, A. (2005) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.81.87 · Cited by 18
Molecular scissors forin situcellular repair
Prìeto, J., Molina, R., & Montoya, G. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.652358 · Cited by 18
Sargent, R. G., Suzuki, S., & Gruenert, D. C. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-761-7_18 · Cited by 17
Advances in CRISPR/Cas9-mediated genome editing on vegetable crops
Tian, S., Xing, S., & Xu, Y. (2021) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-021-10187-z · Cited by 17
Karnan, S., Ota, A., Konishi, Y., Wahiduzzaman, M., Hosokawa, Y., & Konishi, H. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1338 · Cited by 17
Genome Engineering in Human Cells
Song, M., Kim, Y., Kim, J., & Kim, S. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801185-0.00005-2 · Cited by 18
Gene Editing for Inherited Red Blood Cell Diseases
Bustamante, O. Q., Fañanas-Baquero, S., Dessy-Rodríguez, M., Ojeda-Pérez, I., & Segovia, J. C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.848261 · Cited by 20
Treating hemoglobinopathies using gene-correction approaches: promises and challenges
Cottle, R. N., Lee, C. M., & Bao, G. (2016) · Human Genetics · doi:10.1007/s00439-016-1696-0 · Cited by 17
Gene Therapy - Developments and Future Perspectives
Kang, C. (2011) · InTech eBooks · doi:10.5772/748 · Cited by 16
Goshayeshi, L., Taemeh, S. Y., Dehdilani, N., Nasiri, M., Seno, M. M. G., & Dehghani, H. (2021) · The FASEB Journal · doi:10.1096/fj.202001830rr · Cited by 16
Therapeutic Application of Genome Editing Technologies in Viral Diseases
Kim, T. H., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105399 · Cited by 19
Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome
Naseem, A., Steinberg, Z., & Cavazza, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.966084 · Cited by 16
Astonishing advances in mouse genetic tools for biomedical research
Jackson, W. S., & Kaczmarczyk, L. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14186 · Cited by 15
Zinc Finger Nuclease induced DNA double stranded breaks and rearrangements in MLL
Do, T. U., Ho, B., Shih, S., & Vaughan, A. T. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.12.006 · Cited by 16
Simple Monitoring of Gene Targeting Efficiency in Human Somatic Cell Lines Using the PIGA Gene
Karnan, S., Konishi, Y., Ota, A., Takahashi, M., Damdindorj, L., Hosokawa, Y., & Konishi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047389 · Cited by 16
Kalra, S., Montanaro, F., & Denning, C. N. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150133 · Cited by 17
Regulation of gene expression: probing DNA–protein interactionsin vivoandin vitro
Vigneault, F., & Guérin, S. L. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.5.705 · Cited by 16
Thibodeau-Beganny, S., Maeder, M. L., & Joung, J. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-753-2_2 · Cited by 16
Piedrahita, J. A., Mir, B., Dindot, S. V., & Walker, S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000110183.87476.05 · Cited by 16
Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances
Mei, J., Ding, P., Gao, C., Zhou, J., Li, Z., Zhang, C., & Gao, J. (2025) · MedComm · doi:10.1002/mco2.70385 · Cited by 17
A Curative DNA Code for Hematopoietic Defects
Porteus, M. H., Pavel-Dinu, M., & Pai, S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.05.002 · Cited by 15
Self-citationHuang, C., Li, Q., & Li, J. (2022) · Medical Review · doi:10.1515/mr-2022-0029 · Cited by 20
Wang, H., Zhao, R., Zhang, B., Xiao, Y., Yu, C., Wang, Y., Yu, C., Tang, Y., Li, Y., Lu, B., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202423473 · Cited by 15
Delivering the Goods for Genome Engineering and Editing
Skipper, K. A., & Mikkelsen, J. G. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.063 · Cited by 16
Shen, B., Zhang, X., Du, Y., Wang, J., Gong, J., Zhang, X., Tate, P. H., Li, H., Huang, X., & Zhang, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077696 · Cited by 15
Validation and Expression of Zinc Finger Nucleases in Plant Cells
Tovkach, A., Zeevi, V., & Tzfira, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-753-2_20 · Cited by 15
Matsuda, T., & Oinuma, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-47721-4 · Cited by 13
CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA
Zhang, Q., Fu, Y., Thakur, C., Bi, Z., Wadgaonkar, P., Qiu, Y., Xu, L., Rice, M., Zhang, W., Almutairy, B. S., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.145 · Cited by 15
Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics
Matos, M. R., Ho, S., Schrode, N., & Brennand, K. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103532 · Cited by 15
Nucleases for genome editing in crops
Kathiria, P., & Eudes, F. (2013) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2013.12.006 · Cited by 15
Barker, J. C., Barker, A. D., Bills, J. D., Huang, J., Wight‐Carter, M., Delgado, I., Noble, D. L., Huang, L. J.-S., Porteus, M. H., & Davis, K. E. (2014) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000000427 · Cited by 15
Self-citationShieh, J., Cheng, Y., Su, M., Moore, M., Choo, Y., & Klug, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000746 · Cited by 15
AAV vectors for gene correction.
Cathomen, T. (2004) · PubMed · Cited by 15
AAV-Mediated Gene Editing via Double-Strand Break Repair
Hirsch, M. L., & Samulski, R. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-761-7_19 · Cited by 14
Engineering imaging probes and molecular machines for nanomedicine
Tong, S., Cradick, T. J., Ma, Y., Dai, Z., & Bao, G. (2012) · Science China Life Sciences · doi:10.1007/s11427-012-4380-1 · Cited by 15
Mandai, S., Mori, T., Sohara, E., Rai, T., & Uchida, S. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05872 · Cited by 14
Redesigning Recombinase Specificity for Safe Harbor Sites in the Human Genome
Wallen, M. C., Gaj, T., & Barbas, C. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139123 · Cited by 14
Liu, Z., Cheng, T., Shi, Z., Liu, Z., Lei, Y., Wang, C., Shi, W., Chen, X., Qi, X., Cai, D., et al. (2016) · Cell & Bioscience · doi:10.1186/s13578-016-0088-4 · Cited by 14
Efficient Homology-directed Repair with Circular ssDNA DonorsPreprint
Iyer, S., Mir, A., Vega‐Badillo, J., Roscoe, B. P., Ibraheim, R., Zhu, L. J., Lee, J., Liu, P., Luk, K., Mintzer, E., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/864199 · Cited by 14
Simple Meets Single: The Application of CRISPR/Cas9 in Haploid Embryonic Stem Cells
Yin, Z., & Chen, L. (2017) · Stem Cells International · doi:10.1155/2017/2601746 · Cited by 13
A short, idiosyncratic history of genome editing
Carroll, D. (2021) · Gene and Genome Editing · doi:10.1016/j.ggedit.2021.100002 · Cited by 14
Papaioannou, I., Simons, J. P., & Owen, J. S. (2012) · Cardiology Research and Practice · doi:10.1155/2012/148796 · Cited by 15
Gelato, K. A., Martin, S. S., Liu, P. H., Saunders, A. A., & Baldwin, E. P. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.058 · Cited by 13
Kurome, M., Leuchs, S., Keßler, B., Kemter, E., Jemiller, E., Förster, B., Klymiuk, N., Zakhartchenko, V., & Wolf, E. (2016) · Transgenic Research · doi:10.1007/s11248-016-0004-z · Cited by 13
Gene therapy and its application in dermatology
Sarkar, S., Sarkar, T., & Gangopadhyay, D. (2020) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_323_20 · Cited by 13
Gene editing as a promising approach for respiratory diseases
Bai, Y., Liu, Y., Su, Z., Ma, Y., Ren, C., Zhao, R., & Ji, H. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104960 · Cited by 15
Investigation of arc repressor DNA-binding specificity by comparative molecular dynamics simulations
Song, W., & Guo, J. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.997797 · Cited by 13
Pointing fingers at the limiting step in gene targeting
Wilson, J. H. (2003) · Nature Biotechnology · doi:10.1038/nbt0703-759 · Cited by 13
Horner, S. M., & DiMaio, D. (2007) · Journal of Virology · doi:10.1128/jvi.00232-07 · Cited by 13
Gene therapy for primary immunodeficiencies
Kildebeck, E., Checketts, J., & Porteus, M. H. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328359e480 · Cited by 13
Self-citationXiao, D., Zhang, W., Li, Y., Liu, K., Zhao, J., Sun, X., Shan, L., Mao, Q., & Xia, H. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.12.026 · Cited by 12
Synthetische Biologie – die Synthese der Biologie
Ausländer, S., Ausländer, D., & Fussenegger, M. (2016) · Angewandte Chemie · doi:10.1002/ange.201609229 · Cited by 12
Prat, F., Toutain, J., Boutin, J., Amintas, S., Cullot, G., Lalanne, M., Lamrissi‐Garcia, I., Moranvillier, I., Richard, E., Blouin, J., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.07.015 · Cited by 13
Defining and targeting patterns of T cell dysfunction in inborn errors of immunity
Campos, J. S., & Henrickson, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932715 · Cited by 12
Megagiannis, P., Suresh, R., Rouleau, G. A., & Zhou, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114562 · Cited by 12
From Marrow to Matrix: Novel Gene and Cell Therapies for Epidermolysis Bullosa
Webber, B. R., & Tolar, J. (2015) · Molecular Therapy · doi:10.1038/mt.2015.47 · Cited by 13
Targeted Gene Correction with 5′ Acridine-Oligonucleotide Conjugates
de Piédoue, G., Andrieu‐Soler, C., Concordet, J., Maurisse, R., Sun, J., López, B. S., Kuzniak, I., Leboulch, P., & Feugeas, J. (2007) · Oligonucleotides · doi:10.1089/oli.2007.0074 · Cited by 12
A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
Porter, S. N., Levine, R. M., & Pruett‐Miller, S. M. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180022 · Cited by 18
Wang, M., Schedel, M., & Gelfand, E. W. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.03.016 · Cited by 11
Gene editing technology: Towards precision medicine in inherited retinal diseases
Ballios, B. G., Pierce, E. A., & Huckfeldt, R. M. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1887903 · Cited by 11
The history of genome editing: advances from the interface of chemistry & biology
Matsumoto, D., & Nomura, W. (2023) · Chemical Communications · doi:10.1039/d3cc00559c · Cited by 15
Targeted mutagenesis of zebrafish: Use of zinc finger nucleases
Leong, I. U. S., Lai, D., Lan, C.-C., Johnson, R., Love, D. R., Johnson, R., & Love, D. R. (2011) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20213 · Cited by 11
Zhang, C., Xu, K., Hu, L., Wang, L., Zhang, T., Ren, C., & Zhang, Z. (2014) · Biotechnology Letters · doi:10.1007/s10529-014-1690-3 · Cited by 11
Zhao, Z., Zhang, H., Xiong, T., Wang, J., Yang, D., Zhu, D., Li, J., Yang, Y., Sun, C., Zhao, Y., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165821 · Cited by 11
Recent advances in yeast genome evolution with stress tolerance for green biological manufacturing
Xu, K., Zhang, Y., Guo, D., Qin, L., Ashraf, M. U., & Ahmad, N. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28183 · Cited by 11
Lee, H., Lee, S., & Park, Y. (2019) · Environmental Research · doi:10.1016/j.envres.2019.01.027 · Cited by 10
Genome Editing in Human Pluripotent Stem CellsPreprint
Smith, C. J., Ye, Z., & Cheng, L. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top086819 · Cited by 11
Homologous recombination‐based gene therapy for the primary immunodeficiencies
Porteus, M. H. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06314.x · Cited by 10
Self-citationGao, B., Sabnis, R., Costantini, T., Jinkerson, R. E., & Sun, Q. H. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190172 · Cited by 10
A primer on metabolic memory: why existing diabesity treatments fail
Çöpür, S., Rossing, P. R., Afşar, B., Sag, A. A., Siriopol, D. C., Kuwabara, M., Ortíz, A., & Kanbay, M. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa143 · Cited by 10
Verhagen, H. J. M. P., Kuijk, C., Rutgers, L., Kokke, A. M., van der Meulen, S. A., van Mierlo, G. J., Voermans, C., & van den Akker, E. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0112 · Cited by 10
Genome Editing of the Blood: Opportunities and Challenges
Porteus, M. H. (2015) · Current Stem Cell Reports · doi:10.1007/s40778-014-0003-z · Cited by 10
Self-citationYang, J., Liu, X., Yu, J., Liang, S., Shi, Y., Li, Z., Hu, Y., Xue, J., Wu, L., Liang, Y., et al. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp080 · Cited by 10
Genome Editing Technologies as Cellular Defense Against Viral Pathogens
Zhang, Y., & Li, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716344 · Cited by 10
Rare immune diseases paving the road for genome editing-based precision medicine
Pavel-Dinu, M., Borna, Š., & Bacchetta, R. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1114996 · Cited by 10
Gene Site-Specific Insertion in Plants
Ines, O. D., & White, C. I. (2012) · Topics in current genetics · doi:10.1007/978-94-007-4531-5_11 · Cited by 10
Genome editing: the breakthrough technology for inherited retinal disease?
Smith, A. J., Carter, S. P., & Kennedy, B. N. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1347629 · Cited by 10
Genome editing for human osteoarthritis – a perspective
Almarza, D., Cucchiarini, M., & Loughlin, J. A. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.05.003 · Cited by 10
Transgene integration in mammalian cells: The tools, the challenges, and the future
Fong, J. H. C., & Ceroni, F. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101426 · Cited by 15
Cheng, L., Blazar, B. R., High, K. A., & Porteus, M. H. (2011) · Nature Medicine · doi:10.1038/nm1011-1192 · Cited by 9
Self-citationAn EM View of the FokI Synaptic Complex by Single Particle Analysis
Vanamee, É. S., Berriman, J. A., & Aggarwal, A. K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.066 · Cited by 9
Methods of genome engineering: a new era of molecular biology
Chugunova, A. A., Донцова, О. А., & Владимирович, С. П. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916070038 · Cited by 9
Fan, B., Huang, P., Zheng, S., Sun, Y., Fang, C., & Sun, Z. (2011) · Animal Biotechnology · doi:10.1080/10495398.2011.626885 · Cited by 9
Turkki, V., Schenkwein, D., Timonen, O., Husso, T., Lesch, H. P., & Ylä‐Herttuala, S. (2014) · BioMed Research International · doi:10.1155/2014/379340 · Cited by 9
Metadata
- Authors
- Porteus, M. H., & Baltimore, D.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- Porteus, Matthew H.
- Baltimore, David
- Venue
- Science
- Published
- 2003-05-02
- Volume
- 300
- Issue
- 5620
- Pages
- 763-763
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2051395442
- Cited by
- 741
- References
- 10
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 25 · 2023: 16 · 2022: 26 · 2021: 30 · 2020: 34 · 2019: 33 · 2018: 27 · 2017: 28 · 2016: 52 · 2015: 45 · 2014: 69 · 2013: 41 · 2012: 51
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM039458, R01 GM39458)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- gene targeting, homologous recombination, zinc finger DNA-binding domain, DNA double-strand breaks, linker length, somatic cell therapy, gene therapy vectors, somatic cell hybrids, somatic cell nuclear transfer
- MeSH terms
- Cell Line, DNA, Humans, Luminescent Proteins, Mutation, Recombinant Fusion Proteins, Recombination, Genetic, Transfection, Deoxyribonucleases, Type II Site-Specific, Zinc Fingers, Gene Targeting, Dimerization, Nuclear Localization Signals, Saccharomyces cerevisiae Proteins, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review